These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 8551217)

  • 1. Lipoxin A4 and B4 are potent stimuli for human monocyte migration and adhesion: selective inactivation by dehydrogenation and reduction.
    Maddox JF; Serhan CN
    J Exp Med; 1996 Jan; 183(1):137-46. PubMed ID: 8551217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipoxin A4 and lipoxin B4 stimulate the release but not the oxygenation of arachidonic acid in human neutrophils: dissociation between lipid remodeling and adhesion.
    Nigam S; Fiore S; Luscinskas FW; Serhan CN
    J Cell Physiol; 1990 Jun; 143(3):512-23. PubMed ID: 2162850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of human monocytes and the acute monocytic leukemia cell line (THP-1) by lipoxins involves unique signaling pathways for lipoxin A4 versus lipoxin B4: evidence for differential Ca2+ mobilization.
    Romano M; Maddox JF; Serhan CN
    J Immunol; 1996 Sep; 157(5):2149-54. PubMed ID: 8757340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipoxin A4 and lipoxin B4 inhibit chemotactic responses of human neutrophils stimulated by leukotriene B4 and N-formyl-L-methionyl-L-leucyl-L-phenylalanine.
    Lee TH; Horton CE; Kyan-Aung U; Haskard D; Crea AE; Spur BW
    Clin Sci (Lond); 1989 Aug; 77(2):195-203. PubMed ID: 2548801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoxin B4 regulates human monocyte/neutrophil adherence and motility: design of stable lipoxin B4 analogs with increased biologic activity.
    Maddox JF; Colgan SP; Clish CB; Petasis NA; Fokin VV; Serhan CN
    FASEB J; 1998 Apr; 12(6):487-94. PubMed ID: 9535221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipoxin A4 stable analogs are potent mimetics that stimulate human monocytes and THP-1 cells via a G-protein-linked lipoxin A4 receptor.
    Maddox JF; Hachicha M; Takano T; Petasis NA; Fokin VV; Serhan CN
    J Biol Chem; 1997 Mar; 272(11):6972-8. PubMed ID: 9054386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipoxin A4 metabolism by differentiated HL-60 cells and human monocytes: conversion to novel 15-oxo and dihydro products.
    Serhan CN; Fiore S; Brezinski DA; Lynch S
    Biochemistry; 1993 Jun; 32(25):6313-9. PubMed ID: 8518275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipoxin A4 and B4 inhibit leukotriene-stimulated interactions of human neutrophils and endothelial cells.
    Papayianni A; Serhan CN; Brady HR
    J Immunol; 1996 Mar; 156(6):2264-72. PubMed ID: 8690917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutrophil-mediated changes in vascular permeability are inhibited by topical application of aspirin-triggered 15-epi-lipoxin A4 and novel lipoxin B4 stable analogues.
    Takano T; Clish CB; Gronert K; Petasis N; Serhan CN
    J Clin Invest; 1998 Feb; 101(4):819-26. PubMed ID: 9466977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design of lipoxin A4 stable analogs that block transmigration and adhesion of human neutrophils.
    Serhan CN; Maddox JF; Petasis NA; Akritopoulou-Zanze I; Papayianni A; Brady HR; Colgan SP; Madara JL
    Biochemistry; 1995 Nov; 34(44):14609-15. PubMed ID: 7578068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of lipoxin A4 on chemotaxis and degranulation of human eosinophils stimulated by platelet-activating factor and N-formyl-L-methionyl-L-leucyl-L-phenylalanine.
    Soyombo O; Spur BW; Lee TH
    Allergy; 1994 Apr; 49(4):230-4. PubMed ID: 8037356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipoxin A4 modulates transmigration of human neutrophils across intestinal epithelial monolayers.
    Colgan SP; Serhan CN; Parkos CA; Delp-Archer C; Madara JL
    J Clin Invest; 1993 Jul; 92(1):75-82. PubMed ID: 8326019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aromatic lipoxin A4 and lipoxin B4 analogues display potent biological activities.
    O'Sullivan TP; Vallin KS; Shah ST; Fakhry J; Maderna P; Scannell M; Sampaio AL; Perretti M; Godson C; Guiry PJ
    J Med Chem; 2007 Nov; 50(24):5894-902. PubMed ID: 17960922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipoxin generation by permeabilized human platelets.
    Romano M; Serhan CN
    Biochemistry; 1992 Sep; 31(35):8269-77. PubMed ID: 1381961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a novel 7-cis-11-trans-lipoxin A4 generated by human neutrophils: total synthesis, spasmogenic activities and comparison with other geometric isomers of lipoxins A4 and B4.
    Nicolaou KC; Marron BE; Veale CA; Webber SE; Dahlén SE; Samuelsson B; Serhan CN
    Biochim Biophys Acta; 1989 May; 1003(1):44-53. PubMed ID: 2713393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesenteric vascular responses to i.v. administration of lipoxin A4 and lipoxin B4 in the conscious rat.
    Feuerstein G; Siren AL
    FEBS Lett; 1988 May; 232(1):51-5. PubMed ID: 3366247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolism of lipoxins A4 and B4 and of their all-trans isomers by human leukocytes and rat liver microsomes.
    Boucher JL; Delaforge M; Mansuy D
    Biochem Biophys Res Commun; 1991 May; 177(1):134-9. PubMed ID: 2043100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipoxin A4 receptor activation is distinct from that of the formyl peptide receptor in myeloid cells: inhibition of CD11/18 expression by lipoxin A4-lipoxin A4 receptor interaction.
    Fiore S; Serhan CN
    Biochemistry; 1995 Dec; 34(51):16678-86. PubMed ID: 8527441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipoxin recognition sites. Specific binding of labeled lipoxin A4 with human neutrophils.
    Fiore S; Ryeom SW; Weller PF; Serhan CN
    J Biol Chem; 1992 Aug; 267(23):16168-76. PubMed ID: 1322894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipoxin and synthetic lipoxin analogs: an overview of anti-inflammatory functions and new concepts in immunomodulation.
    Parkinson JF
    Inflamm Allergy Drug Targets; 2006 Apr; 5(2):91-106. PubMed ID: 16613568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.